Villacrusis, John Bryce M.
HRN: 28-55-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2026
CEFUROXIME 750MG (VIAL)
07/13/2026
07/21/2026
IVT
750mg
Q8
Acute Pyelonephritis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes